Physician profile
Stephen T Rothbart
NPI 1497724876
$4,445.80
in general payments reported to CMS, 2019-2025
19 companies · $1,627 in 2025
The $1,627 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $57.19 · 2021: $229 · 2022: $139 · 2023: $883 · 2024: $1,295 · 2025: $1,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,953 · Travel and Lodging: $1,721 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.68 |
| Travel and Lodging | $1,721.48 |
| Education | $131.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,549.82 | 2019-2025 | Aveir, Gallant |
| Medtronic, INC. | $1,079.06 | 2024-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $761.83 | 2019-2024 | Watchman, Watchman Access System, Watchman Flx |
| Atricure, INC. | $271.82 | 2020-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $256.58 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $90.99 | 2019 | |
| Impulse Dynamics (USA) INC. | $61.35 | 2023-2024 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $55.83 | 2021-2022 | |
| Altathera Pharmaceuticals LLC | $52.93 | 2020-2025 | Sotalol Hydrochloride |
| Pfizer INC. | $48.45 | 2023-2025 | |
| Cvrx, INC. | $43.64 | 2023 | Barostim Neo System |
| Vital Connect, INC | $34.97 | 2025 | Vitalpatch Rtm |
| Medicomp INC | $28.44 | 2025 | Telepatch Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $25.52 | 2020-2022 | |
| Irhythm Technologies, INC. | $24.63 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $19.40 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $15.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rothbart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.